BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Infographics: Dynamic digital data analysis
Trump administration impacts
Biopharma M&A scorecard
BioWorld 2024 review
BioWorld MedTech 2024 review
BioWorld Science 2024 review
Women's health
China's GLP-1 landscape
PFA re-energizes afib market
China CAR T
Alzheimer's disease
Israel
Rise of obesity
Radiopharmaceuticals
Biosimilars
Aging
IVDs on the rise
Coronavirus
Artificial intelligence
BioWorld. Link to homepage.
Sign In
Sign Out
My Account
Subscribe
BioWorld - Saturday, April 19, 2025
See today's BioWorld
Home
» In the clinic for Sept. 13, 2023
To read the full article
sign up for free
or
sign in
.
In the clinic for Sept. 13, 2023
Sep. 13, 2023
Clinical updates, including trial initiations, enrollment status and data readouts and publications: Abbvie, Acelyrin, Aerami, Aim, Algo, Altimmune, Anokion, Artiva, Arrowhead, Astrazeneca, Avalyn, Curevac, Day One, Dianthus, Foresee, GSK, Humacyte, Hutchmed, IO Biotech, Lisata, Lyra, Mindmed, Myeloid, Neurocrine, Nextcure, Nuvectis, Ose, Replicate, RS Oncology, Sorrento, Sparrow, Valbiotis, Vistagen.
BioWorld
Briefs
In the clinic
Coronavirus